These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 23810574

  • 1. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Assifi MM, Zhang S, Leiby BE, Pequignot EC, Xia B, Rosato E, Lavu H, Kennedy EP, Yeo CJ, Berger AC.
    J Am Coll Surg; 2013 Oct; 217(4):621-7. PubMed ID: 23810574
    [Abstract] [Full Text] [Related]

  • 2. Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula.
    Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A, Hayashi M, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakao A.
    Ann Surg Oncol; 2011 Aug; 18(8):2329-37. PubMed ID: 21327822
    [Abstract] [Full Text] [Related]

  • 3. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors.
    Fuks D, Piessen G, Huet E, Tavernier M, Zerbib P, Michot F, Scotte M, Triboulet JP, Mariette C, Chiche L, Salame E, Segol P, Pruvot FR, Mauvais F, Roman H, Verhaeghe P, Regimbeau JM.
    Am J Surg; 2009 Jun; 197(6):702-9. PubMed ID: 18778804
    [Abstract] [Full Text] [Related]

  • 4. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
    Serrano PE, Kim D, Kim PT, Greig PD, Moulton CA, Gallinger S, Wei AC, Cleary SP.
    Am Surg; 2016 Dec 01; 82(12):1187-1195. PubMed ID: 28234183
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma.
    Neeman U, Lahat G, Goykhman Y, Geva R, Peles-Avraham S, Nachmany I, Nakache R, Klausner JM, Lubezky N.
    Surgeon; 2020 Feb 01; 18(1):24-30. PubMed ID: 31466841
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association.
    Addeo P, Delpero JR, Paye F, Oussoultzoglou E, Fuchshuber PR, Sauvanet A, Sa Cunha A, Le Treut YP, Adham M, Mabrut JY, Chiche L, Bachellier P, French Surgical Association (AFC).
    HPB (Oxford); 2014 Jan 01; 16(1):46-55. PubMed ID: 23461663
    [Abstract] [Full Text] [Related]

  • 7. Risk factors of pancreatic fistula after pancreaticoduodenectomy - patients with low drain amylase level on postoperative day 1 are safe from developing pancreatic fistula.
    Tsujie M, Nakamori S, Miyamoto A, Yasui M, Ikenaga M, Hirao M, Fujitani K, Mishima H, Tsujinaka T.
    Hepatogastroenterology; 2012 Jan 01; 59(120):2657-60. PubMed ID: 22497944
    [Abstract] [Full Text] [Related]

  • 8. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T, Hugenschmidt H, Fagerland MW, Ikdahl T, Buanes T, Labori KJ.
    Eur J Surg Oncol; 2013 Jun 01; 39(6):559-66. PubMed ID: 23498362
    [Abstract] [Full Text] [Related]

  • 9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P, de Figueiredo RS, Leaver H, Ogston S, Kulli C, Polignano FM, Tait IS.
    JOP; 2012 Mar 10; 13(2):199-204. PubMed ID: 22406601
    [Abstract] [Full Text] [Related]

  • 10. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
    Goh BK, Tan YM, Chung YF, Cheow PC, Ong HS, Chan WH, Chow PK, Soo KC, Wong WK, Ooi LL.
    Arch Surg; 2008 Oct 10; 143(10):956-65. PubMed ID: 18936374
    [Abstract] [Full Text] [Related]

  • 11. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA.
    Eur J Surg Oncol; 2012 Apr 10; 38(4):333-9. PubMed ID: 22317758
    [Abstract] [Full Text] [Related]

  • 12. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang H.
    Am J Surg Pathol; 2015 Oct 10; 39(10):1395-403. PubMed ID: 26200098
    [Abstract] [Full Text] [Related]

  • 13. Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy.
    Oussoultzoglou E, Bachellier P, Bigourdan JM, Weber JC, Nakano H, Jaeck D.
    Arch Surg; 2004 Mar 10; 139(3):327-35. PubMed ID: 15006893
    [Abstract] [Full Text] [Related]

  • 14. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
    Malleo G, Mazzarella F, Malpaga A, Marchegiani G, Salvia R, Bassi C, Butturini G.
    Surgery; 2013 May 10; 153(5):641-50. PubMed ID: 23276391
    [Abstract] [Full Text] [Related]

  • 15. Triple-layer duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa decreased pancreatic fistula after pancreaticoduodenectomy.
    Su AP, Zhang Y, Ke NW, Lu HM, Tian BL, Hu WM, Zhang ZD.
    J Surg Res; 2014 Jan 10; 186(1):184-91. PubMed ID: 24095023
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM, Croagh D, Coldham C, Tanière P, Buckels J, Isaac J, Mayer D, Muiesan P, Bramhall S, Mirza DF.
    Eur J Surg Oncol; 2012 Jan 10; 38(1):72-9. PubMed ID: 22054617
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience).
    El Nakeeb A, El Shobary M, El Dosoky M, Nabeh A, El Sorogy M, El Eneen AA, abu Zeid M, Elwahab MA.
    Hepatogastroenterology; 2014 Jan 10; 61(133):1426-38. PubMed ID: 25436321
    [Abstract] [Full Text] [Related]

  • 18. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.
    Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H, Nakeeb A, Pitt HA, Lillemoe KD, Yeo CJ.
    J Am Coll Surg; 2009 May 10; 208(5):738-47; discussion 747-9. PubMed ID: 19476827
    [Abstract] [Full Text] [Related]

  • 19. Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
    Lubrano J, Bachelier P, Paye F, Le Treut YP, Chiche L, Sa-Cunha A, Turrini O, Menahem B, Launoy G, Delpero JR.
    Eur J Surg Oncol; 2018 Jul 10; 44(7):1078-1082. PubMed ID: 29685757
    [Abstract] [Full Text] [Related]

  • 20. Pancreatogastrostomy as a salvage procedure to treat severe postoperative pancreatic fistula after pancreatoduodenectomy.
    Bachellier P, Oussoultzoglou E, Rosso E, Scurtu R, Lucescu I, Oshita A, Jaeck D.
    Arch Surg; 2008 Oct 10; 143(10):966-70; discussion 971. PubMed ID: 18936375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.